Antibe Therapeutics Inc (ATE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2013 | 03-2012 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 194 | 93 |
| Receivables | 217 | 18 |
| TOTAL | $457 | $115 |
| Non-Current Assets | ||
| Other Non-Current Assets | 281 | 56 |
| TOTAL | $281 | $56 |
| Total Assets | $738 | $171 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 762 | N/A |
| Accounts payable and accrued liabilities | 537 | 136 |
| TOTAL | $1,299 | $397 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 446 | 0 |
| TOTAL | $446 | $0 |
| Total Liabilities | $1,745 | $397 |
| Shareholders' Equity | ||
| Common Shares | 1,372 | 1,320 |
| Retained earnings | -3,894 | -2,849 |
| Other shareholders' equity | 449 | 416 |
| TOTAL | $-1,007 | $-226 |
| Total Liabilities And Equity | $738 | $171 |